Fellowship · Tucson, AZ
Sponsored by University of Arizona College of Medicine-Tucson
Lung-function trajectories: relevance and implementation in clinical practice.
Lancet (London, England) · 2024 · 122 citations · Fernando Martinez
Discontinuation versus continuation of hypertonic saline or dornase alfa in modulator treated people with cystic fibrosis (SIMPLIFY): results from two parallel, multicentre, open-label, randomised, controlled, non-inferiority trials.
The Lancet. Respiratory medicine · 2023 · 109 citations · Susan Millard
Treatment Trials in Young Patients with Chronic Obstructive Pulmonary Disease and Pre-Chronic Obstructive Pulmonary Disease Patients: Time to Move Forward.
American journal of respiratory and critical care medicine · 2022 · 139 citations · Fernando Martinez
Early-Life Exposure to Air Pollution and Childhood Asthma Cumulative Incidence in the ECHO CREW Consortium.
JAMA network open · 2024 · 64 citations · Fernando Martinez
Childhood Asthma Incidence, Early and Persistent Wheeze, and Neighborhood Socioeconomic Factors in the ECHO/CREW Consortium.
JAMA pediatrics · 2022 · 121 citations · Fernando Martinez
Safety and Efficacy of Elexacaftor/Tezacaftor/Ivacaftor for 24 Weeks or Longer in People with Cystic Fibrosis and One or More F508del Alleles: Interim Results of an Open-Label Phase 3 Clinical Trial.
American journal of respiratory and critical care medicine · 2021 · 146 citations ·
Genes, Environments, and Time: The Biology of Adversity and Resilience.
Pediatrics · 2021 · 140 citations · Fernando Martinez
Long-term safety and efficacy of elexacaftor/tezacaftor/ivacaftor in people with cystic fibrosis and at least one F508del allele: 144-week interim results from a 192-week open-label extension study.
The European respiratory journal · 2023 · 85 citations · Cori Daines